BioSpace News Archive

In addition, Nuvectra has granted the underwriters a 30-day option to purchase up to 423,750 additional shares of common stock on the same terms and conditions.

CytoSorbents highlights the recent publication entitled, “Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation - an observational study” in the medical journal Clinical Transplantation

Alnylam announced today that it will report financial results for the fourth quarter and year ending December 31, 2017 on Thursday, February 8, 2018, before the U.S. financial markets open.

Baxter International, Inc. today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.

Going forward, the existing Resonetics management team, led by CEO Tom Burns, will continue in their existing roles as a subsidiary of Regatta Medical.

Certara Corporation, the global leader in model-informed drug development and regulatory science, today announced that it has acquired BaseCase Management GmbH, a data visualization software as a service (SaaS) company headquartered in Berlin, Germany, with offices in New York

DexCom today announced that it plans to release its fourth quarter and full year 2017 financial results after market close on Tuesday, February 27, 2018.

Mallinckrodt today announced that Mark Casey has been appointed General Counsel, effective immediately.

OncoSec Medical announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock at a price of $1.50 per share, with expected gross proceeds of approximately $20 million, before deducting underwriting discounts and commissions and estimated offering expenses paid by OncoSec.

PPD today announced that Maria Teresa Hilado, chief financial officer of Allergan, has been named to PPD’s board of directors.